Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) 41st Annual J.P. Morgan Healthcare Conference January 11, 2023 1:30 PM ET Company Participants Eli Kalif - Executive Vice President and Chief Financial Officer Richard Francis - President and CEO Conference Call Participants Chris Schott - JPMorgan Chris Schott Good morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Teva this morning. From the company, we have the company's recently appointed CEO, Richard Francis; as well ...

| --- | --- | |----------------------------------------------------------------|-------| | | | | | | | Teva Pharmaceutical Industries Ltd. Third Quarter 2022 Results | | | November 3, 2022 | | Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks and uncertainties, both known and ...

| --- | --- | |-----------------------------|-------| | | | | Second Quarter 2022 Results | | | July 27, 2022 | | Agenda 1 Opioid litigation updates 2 Second quarter 2022 results 3 Strategy update and 2027 long-term financial targets 4 Q&A teva Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to ...

Teva Pharmaceutical Industries Ltd. First Quarter 2022 Results May 3, 2022 Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed ...

| --- | --- | |-------------------------------------|-------| | | | | | | | | | | | | | | | | Teva Pharmaceutical Industries Ltd. | | | Fourth Quarter and Full Year | | | 2021 Results | | | February 9, 2022 | | Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks and uncertaintie ...

| --- | --- | |-------------------------------------|-------| | | | | | | | | | | | | | | | | Teva Pharmaceutical Industries Ltd. | | | J.P. Morgan Healthcare Conference | | | Kåre Schultz | | | President & CEO | | | January 11, 2022 | | | | | Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to s ...